Allgens Medical: Suspected of false records in financial data, under CSRC investigation

Allgens Medical announced that on November 1, 2026, the company received a "Notice of Case Filing" issued by the China Securities Regulatory Commission. Because the company is suspected of false records in financial data such as periodic reports, the CSRC decided to open a case against the company. If facts subsequently established through administrative penalties touch upon the circumstances for mandatory delisting due to major violations, the company's shares will be subject to mandatory delisting due to major violations. At present, the company's operations and management, business, and financial condition are normal. During the investigation, the company will actively cooperate with the relevant work.